The Clinical and Immunological Features of Patients with Primary Antibody Deficiencies. 2018

Gholamreza Azizi, and Yasser Bagheri, and Marzieh Tavakol, and Forough Askarimoghaddam, and Kumars Porrostami, and Hosein Rafiemanesh, and Reza Yazdani, and Fatemeh Kiaee, and Sima Habibi, and Kosar Abouhamzeh, and Hamed Mohammadi, and Mostafa Qorbani, and Hassan Abolhassani, and Asghar Aghamohammadi
Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.

BACKGROUND Primary antibody deficiency (PAD) comprises a range of diseases from early to late terminal B cells defects and is associated with the various clinical complications. METHODS A total of 461 patients (311 males and 150 females) with PADs enrolled in the retrospective cohort study and for all patients' demographic information, clinical records and laboratory data were collected to investigate clinical complications. RESULTS The most prevalent first presentations of immunodeficiency were respiratory tract infections in 63.5% and chronic diarrhea in 17.2%. Common variable immune deficiency (CVID) patients had a higher diagnostic delay than class switching defect (CSD), and agammaglobulinemia. Among the noninfectious complications, autoimmunity (26.2%), and splenomegaly (23.4%) were the most common. Lymphadenopathy was higher in CSD patients than other PADs, while splenomegaly, hepatomegaly, autoimmunity and bronchiectasis were more common in CVID patients than others. Atopic manifestations were mostly recorded in patients with selective IgA deficiency. Malignancy was only reported in 5.8% of patients with CVID. There was a higher prevalence of autoimmune manifestations in CVID comparing to other PADs. CONCLUSIONS PADs are relatively rare diseases and these patients have a variety of first clinical manifestations, such as diverse infections, autoimmunity, lymphoproliferation, allergy, enteropathy and malignancy. Practitioner's awareness about the heterogeneous presentations of PAD disorders is poor, therefore patients often are lately diagnosed, and they are complicated with several clinical complications before the certain diagnosis.

UI MeSH Term Description Entries
D007153 Immunologic Deficiency Syndromes Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. Antibody Deficiency Syndrome,Deficiency Syndrome, Immunologic,Deficiency Syndromes, Antibody,Deficiency Syndromes, Immunologic,Immunologic Deficiency Syndrome,Immunological Deficiency Syndromes,Antibody Deficiency Syndromes,Deficiency Syndrome, Antibody,Deficiency Syndrome, Immunological,Deficiency Syndromes, Immunological,Immunological Deficiency Syndrome,Syndrome, Antibody Deficiency,Syndrome, Immunologic Deficiency,Syndrome, Immunological Deficiency,Syndromes, Antibody Deficiency,Syndromes, Immunologic Deficiency,Syndromes, Immunological Deficiency
D007223 Infant A child between 1 and 23 months of age. Infants
D007492 Iran A country bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan. The capital is Tehran. Islamic Republic of Iran
D008297 Male Males
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Gholamreza Azizi, and Yasser Bagheri, and Marzieh Tavakol, and Forough Askarimoghaddam, and Kumars Porrostami, and Hosein Rafiemanesh, and Reza Yazdani, and Fatemeh Kiaee, and Sima Habibi, and Kosar Abouhamzeh, and Hamed Mohammadi, and Mostafa Qorbani, and Hassan Abolhassani, and Asghar Aghamohammadi
October 2019, Archivum immunologiae et therapiae experimentalis,
Gholamreza Azizi, and Yasser Bagheri, and Marzieh Tavakol, and Forough Askarimoghaddam, and Kumars Porrostami, and Hosein Rafiemanesh, and Reza Yazdani, and Fatemeh Kiaee, and Sima Habibi, and Kosar Abouhamzeh, and Hamed Mohammadi, and Mostafa Qorbani, and Hassan Abolhassani, and Asghar Aghamohammadi
January 2019, Frontiers in immunology,
Gholamreza Azizi, and Yasser Bagheri, and Marzieh Tavakol, and Forough Askarimoghaddam, and Kumars Porrostami, and Hosein Rafiemanesh, and Reza Yazdani, and Fatemeh Kiaee, and Sima Habibi, and Kosar Abouhamzeh, and Hamed Mohammadi, and Mostafa Qorbani, and Hassan Abolhassani, and Asghar Aghamohammadi
May 2020, Journal of clinical immunology,
Gholamreza Azizi, and Yasser Bagheri, and Marzieh Tavakol, and Forough Askarimoghaddam, and Kumars Porrostami, and Hosein Rafiemanesh, and Reza Yazdani, and Fatemeh Kiaee, and Sima Habibi, and Kosar Abouhamzeh, and Hamed Mohammadi, and Mostafa Qorbani, and Hassan Abolhassani, and Asghar Aghamohammadi
December 2023, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences,
Gholamreza Azizi, and Yasser Bagheri, and Marzieh Tavakol, and Forough Askarimoghaddam, and Kumars Porrostami, and Hosein Rafiemanesh, and Reza Yazdani, and Fatemeh Kiaee, and Sima Habibi, and Kosar Abouhamzeh, and Hamed Mohammadi, and Mostafa Qorbani, and Hassan Abolhassani, and Asghar Aghamohammadi
January 2016, Expert review of clinical immunology,
Gholamreza Azizi, and Yasser Bagheri, and Marzieh Tavakol, and Forough Askarimoghaddam, and Kumars Porrostami, and Hosein Rafiemanesh, and Reza Yazdani, and Fatemeh Kiaee, and Sima Habibi, and Kosar Abouhamzeh, and Hamed Mohammadi, and Mostafa Qorbani, and Hassan Abolhassani, and Asghar Aghamohammadi
December 2009, Clinical medicine (London, England),
Gholamreza Azizi, and Yasser Bagheri, and Marzieh Tavakol, and Forough Askarimoghaddam, and Kumars Porrostami, and Hosein Rafiemanesh, and Reza Yazdani, and Fatemeh Kiaee, and Sima Habibi, and Kosar Abouhamzeh, and Hamed Mohammadi, and Mostafa Qorbani, and Hassan Abolhassani, and Asghar Aghamohammadi
January 2023, Pathogens (Basel, Switzerland),
Gholamreza Azizi, and Yasser Bagheri, and Marzieh Tavakol, and Forough Askarimoghaddam, and Kumars Porrostami, and Hosein Rafiemanesh, and Reza Yazdani, and Fatemeh Kiaee, and Sima Habibi, and Kosar Abouhamzeh, and Hamed Mohammadi, and Mostafa Qorbani, and Hassan Abolhassani, and Asghar Aghamohammadi
December 2018, Rheumatology and therapy,
Gholamreza Azizi, and Yasser Bagheri, and Marzieh Tavakol, and Forough Askarimoghaddam, and Kumars Porrostami, and Hosein Rafiemanesh, and Reza Yazdani, and Fatemeh Kiaee, and Sima Habibi, and Kosar Abouhamzeh, and Hamed Mohammadi, and Mostafa Qorbani, and Hassan Abolhassani, and Asghar Aghamohammadi
July 1972, Recenti progressi in medicina,
Gholamreza Azizi, and Yasser Bagheri, and Marzieh Tavakol, and Forough Askarimoghaddam, and Kumars Porrostami, and Hosein Rafiemanesh, and Reza Yazdani, and Fatemeh Kiaee, and Sima Habibi, and Kosar Abouhamzeh, and Hamed Mohammadi, and Mostafa Qorbani, and Hassan Abolhassani, and Asghar Aghamohammadi
November 2017, Laboratory medicine,
Copied contents to your clipboard!